https://ir.definiumtx.com/news-events/press-r...highlights
August 06, 2026 4:01pm EDT
Webcast Audio: https://definium-earnings-call-q2-aug-2026.op...gistration
Announced positive topline results from Phase 3 Emerge study of DT120 ODT in major depressive disorder (MDD), demonstrating rapid, robust, and durable efficacy
Topline results from Phase 3 GAD studies of DT120 ODT in generalized anxiety disorder (GAD) on track: Voyage results anticipated week of August 10; Panorama results anticipated September 2026
Approximately $1.1 billion in cash, cash equivalents, and investments as of June 30, 2026
Conference call scheduled today at 4:30 p.m. EDT